1. CCLHD Research Repositories

Campbell Tiley

View Statistics Email Alert RSS Feed

Profile

Loading... 2 0 20 0 false
Credit Name
Campbell Tiley
Full Name
Tiley, Campbell
Main Affilation
Central Coast Local Health District
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Subject:  Cancer
Date Issued:  [2010 TO 2019]

Results 1-9 of 9 (Search time: 0.004 seconds).

PreviewIssue DateTitleAuthor(s)
1Dec-2019A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support personsTiley, Campbell ; Stevenson, W.; Bryant, J.; Watson, R.; Sanson-Fisher, R.; Oldmeadow, C.; Henskens, F.; Brown, C.; Ramanathan, S.; Enjeti, A.; Guest, J.; Tzelepis, F.; Paul, C.; D'Este, C.
2May-2017Idarubicin dose escalation during consolidation therapy for adult Acute Myeloid LeukemiaTiley, Campbell ; Bradstock, K.F.; Link, E.; Di Iulio, J.; Szer, J.; Marlton, P.; Wei, A.H.; Enno, A.; Schwarer, A.; Lewis, I.D.; D'Rozario, J.; Coyle, L.; Cull, G.; Campbell, P.; Leahy, M.F.; Hahn, U.; Cannell, P.; Lowenthal, R.M.; Moore, J.; Cartwright, K.; Cunningham, I.; Taper, J.; Grigg, A.; Roberts, A.W.; Benson, W.; Hertzberg, M.; Deveridge, S.; Rowlings, P.; Mills, A.K.; Gill, Devinder S ; Bardy, P.; Campbell, L.J.; Seymour, J.F.
3Jul-2016High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantationTiley, Campbell ; Nath, C.E.; Trotman, J.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; Kwan, Y.L.; Gurney, H.; McLachlan, Andrew ; Earl, J.W.; Nivison-Smith, I.; Zeng, L.; Shaw, P.J.
4Sep-2015Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trialTiley, Campbell ; Iland, H.J.; Collins, M.; Bradstock, K.F.; Supple, S.G.; Catalano, A.; Hertzberg, M.; Browett, P.; Grigg, A.; Firkin, F.; Campbell, L.J.; Hugman, A.; Reynolds, J.; Di Iulio, J.; Taylor, K.; Filshie, R.; Seldon, M.; Taper, J.; Szer, J.; Moore, J.; Bashford, J.; Seymour, J.F.
5Jun-2015Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studiesTiley, Campbell ; Lynagh, M.C.; Clinton-McHarg, T.; Hall, A.; Sanson-Fisher, R.; Stevenson, W.; Bisquera, A.
6Aug-2012All-Trans-Retinoic Acid, Idarubicin, and IV Arsenic Trioxide as initial therapy in Acute Promyelocytic Leukemia (APML4)Iland, H.J.; Bradstock, K.F.; Supple, S.G.; Catalano, A.; Collins, M.; Hertzberg, M.; Browett, P.; Grigg, A.; Firkin, F.; Hugman, A.; Reynolds, J.; Di Iulio, J.; Tiley, Campbell ; Taylor, K.; Filshie, R.; Seldon, M.; Taper, J.; Szer, J.; Moore, J.; Bashford, J.; Seymour, J.F.
7Jun-2012A Phase II Study of Risk-Adapted Intravenous Melphalan in patients with AL AmyloidosisMollee, P.; Tiley, Campbell ; Cunningham, I.; Moore, J.; Prince, M.; Cannell, P.; Gibbons, S.; Tate, J.; Paul, S.; Mar Fan, H.; Gill, Devinder S 
8May-2010Population Pharmacokinetics of Melphalan in Patients with Multiple Myeloma Undergoing High Dose TherapyNath, C.E.; Shaw, P.J.; Trotman, J.; Zeng, L.; Duffull, S.; Hegarty, G.; McLachlan, Andrew ; Gurney, H.; Kerridge, Ian ; Kwan, Yiu Lam ; Presgrave, P.; Tiley, Campbell ; Joshua, D.; Earl, J.W.
9Feb-2010Enrollment of Patients to Clinical Trials in Haematological Cancer in New South Wales: Current Status, Perceived Barriers and Opportunities for ImprovementMurray, P.; Kerridge, Ian ; Tiley, Campbell ; Catanzariti, A.; Welberry, H.; Lean, C.; Sinclair, S.; Bishop, J.; Bradstock, K.F.